Investing
Bio-Techne names new President for Diagnostics, Genomics
© Reuters.
MINNEAPOLIS – Bio-Techne (NASDAQ:) Corporation (NASDAQ:TECH), a global life sciences company, has appointed Matthew F. McManus as President of its Diagnostics and Genomics Segment, starting January 8, 2024. The announcement comes as part of a leadership transition that will see the current Chief Operating Officer, Kim Kelderman, step into the role of Chief Executive Officer on February 1, 2024.
Dr. McManus brings over 20 years of experience in the life sciences industry to his new position. His recent tenure includes serving as the Executive Vice President and Chief Operating Officer at Azenta, overseeing the company’s Life Sciences Products, Services, and commercial operations. He has a history with Bio-Techne, having previously led the company’s Molecular Diagnostics Division after Bio-Techne acquired Asuragen, where Dr. McManus was President and CEO.
His academic credentials are notable, with an M.D. and Ph.D. from the University of Pennsylvania School of Medicine, an MBA from Boston College, and a B.A. in Economics from the College of the Holy Cross. Additionally, he is currently the Chairman of the Board of Directors for ANSA, a firm involved in gene synthesis and cell & gene therapy markets.
Kim Kelderman expressed confidence in Dr. McManus’s appointment, stating his prior success at Bio-Techne and his extensive experience in the life sciences sector position him perfectly to lead the Diagnostics and Genomics Segment into its next growth phase.
Bio-Techne specializes in the development, manufacture, and sale of innovative and high-quality life science reagents, instruments, and services for research, diagnostics, and bioprocessing. The company’s commitment to providing high-quality products and services has made it a trusted partner in the global life sciences community.
The information in this article is based on a press release statement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
5 AI Books Top Entrepreneurs Are Reading in a Rush for 2025
FileJump Offers 2TB of Cloud Storage for $70—With No Strings Attached
It’s Time to Rewrite Your Company’s Values — Here’s How
Say Hello to the PDF Multi-Tool You Didn’t Know You Needed
If you are 60 years old, new 401(k) rules could save you money
5 Things That Could Significantly Impact Your Company in 2025
NFI Group surge after board reshaped with new appointments, chairperson By Investing.com
Microsoft Is About to Begin Job Cuts. Here’s Why.
How Failing 22 Times Paved the Way to My Success
3 Challenges Entrepreneurs Will Face in 2025
Debt ceiling debate and its effect on the U.S. dollar
Debt ceiling default: Still no deal between parties
Stovall: If the U.S. defaults on its debt, all S&P 500 sectors will likely fall
What China's weaker-than-expected economy could mean for U.S. markets
A ‘Big Short’ investor sees financial disaster brewing in housing markets — again
-
Side Hustles6 days ago5 Things That Could Significantly Impact Your Company in 2025
-
Investing6 days agoNFI Group surge after board reshaped with new appointments, chairperson By Investing.com
-
Side Hustles4 days agoMicrosoft Is About to Begin Job Cuts. Here’s Why.
-
Side Hustles7 days agoHow Failing 22 Times Paved the Way to My Success
-
Passive Income5 days ago3 Challenges Entrepreneurs Will Face in 2025
-
Investing7 days agoApple Siri Settlement: Who Is Eligible for a Cash Payout
-
Side Hustles7 days ago3 Strategies to Make Your Next Campaign Go Viral
-
Make Money3 days ago10 Critical Questions to Ask Your Financial Advisor Now